954 related articles for article (PubMed ID: 28148802)
1. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
2. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
3. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
4. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
[TBL] [Abstract][Full Text] [Related]
6. Designing multivalent immunogens for alphavirus vaccine optimization.
Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
[TBL] [Abstract][Full Text] [Related]
7. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
[TBL] [Abstract][Full Text] [Related]
8. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A
Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
11. A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.
Roy CJ; Adams AP; Wang E; Leal G; Seymour RL; Sivasubramani SK; Mega W; Frolov I; Didier PJ; Weaver SC
Vaccine; 2013 Mar; 31(11):1464-70. PubMed ID: 23333212
[TBL] [Abstract][Full Text] [Related]
12. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
[TBL] [Abstract][Full Text] [Related]
13. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
15. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
[TBL] [Abstract][Full Text] [Related]
16. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
17. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
18. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
19. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
